<VariationArchive RecordType="classified" VariationID="13234" VariationName="NM_001114134.2(EPB42):c.175del (p.Val59fs)" VariationType="Deletion" Accession="VCV000013234" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-02-07" DateCreated="2015-11-20" MostRecentSubmission="2015-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="28273" VariationID="13234">
      <GeneList>
        <Gene Symbol="EPB42" FullName="erythrocyte membrane protein band 4.2" GeneID="2038" HGNC_ID="HGNC:3381" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q15.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="43197227" stop="43225737" display_start="43197227" display_stop="43225737" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="43489424" stop="43513322" display_start="43489424" display_stop="43513322" Strand="-" />
          </Location>
          <OMIM>177070</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001114134.2(EPB42):c.175del (p.Val59fs)</Name>
      <CanonicalSPDI>NC_000015.10:43216288:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q15.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="43216289" stop="43216289" display_start="43216289" display_stop="43216289" variantLength="1" positionVCF="43216288" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="43508487" stop="43508487" display_start="43508487" display_stop="43508487" variantLength="1" positionVCF="43508486" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>V89fs</ProteinChange>
      <ProteinChange>V59fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.43216290del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.43216290del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.43508488del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.43508488del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011505.2" sequenceAccession="NG_011505" sequenceVersion="2" change="g.14568del">
            <Expression>NG_011505.2:g.14568del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000119.3" sequenceAccession="NM_000119" sequenceVersion="3" change="c.265del">
            <Expression>NM_000119.3:c.265del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000110.2" sequenceAccession="NP_000110" sequenceVersion="2" change="p.Val89fs">
            <Expression>NP_000110.2:p.Val89fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114134.2" sequenceAccession="NM_001114134" sequenceVersion="2" change="c.175del" MANESelect="true">
            <Expression>NM_001114134.2:c.175del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001107606.1" sequenceAccession="NP_001107606" sequenceVersion="1" change="p.Val59fs">
            <Expression>NP_001107606.1:p.Val59fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1171" sequenceAccession="LRG_1171">
            <Expression>LRG_1171:g.14568del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1171t1" sequenceAccession="LRG_1171t1">
            <Expression>LRG_1171t1:c.265del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1171p1" sequenceAccession="LRG_1171p1" change="p.Val89fs">
            <Expression>LRG_1171p1:p.Val89fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA261249" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="177070.0002" DB="OMIM" />
        <XRef Type="rs" ID="266257354" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001114134.2(EPB42):c.175del (p.Val59fs) AND Hereditary spherocytosis type 5" Accession="RCV000033190" Version="26">
        <ClassifiedConditionList TraitSetID="6706">
          <ClassifiedCondition DB="MedGen" ID="C2675192">Hereditary spherocytosis type 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1995-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-11-20" MostRecentSubmission="2015-11-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">7803799</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6706" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4171" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spherocytosis type 5</ElementValue>
                <XRef ID="Spherocytosis%2C+type+5/9334" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spherocytosis type 5</ElementValue>
                <XRef ID="MONDO:0012985" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPB42-Related Spherocytosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPH5</ElementValue>
                <XRef Type="MIM" ID="612690" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HS5</ElementValue>
                <XRef Type="MIM" ID="612690" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">EPB42-related hereditary spherocytosis (EPB42-HS) is a chronic nonimmune hemolytic anemia that is usually of mild-to-moderate severity. EPB42-HS can present with jaundice as early as the first 24 hours of life or can present later in childhood with anemia resulting from a hemolytic crisis or aplastic crisis (usually associated with a viral infection). In addition to the hematologic manifestations, serious complications include splenomegaly, which can become evident in early childhood, and cholelithiasis, which usually becomes evident in the second or third decade of life. Typical laboratory findings in EPB42-HS include anemia (decreased hemoglobin [Hgb] level) and reticulocytosis (increased percentage of reticulocytes), with high mean corpuscular Hgb concentration, presence of spherocytes in the peripheral blood smear, significantly decreased or absent haptoglobin, mildly increased osmotic fragility in osmotic fragility assay, increased Omin (osmolality at which 50% of red blood cells hemolyze), and decreased maximal elongation index (EImax) in osmotic gradient ektacytometry.</Attribute>
                <XRef ID="NBK190102" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24624460</ID>
                <ID Source="BookShelf">NBK190102</ID>
              </Citation>
              <XRef ID="822" DB="Orphanet" />
              <XRef ID="C2675192" DB="MedGen" />
              <XRef ID="MONDO:0012985" DB="MONDO" />
              <XRef Type="MIM" ID="612690" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="95230" SubmissionDate="2015-11-18" DateLastUpdated="2015-11-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="177070.0002_SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-LISBOA" title="EPB42, 1-BP DEL, 264G_SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-LISBOA" />
        <ClinVarAccession Accession="SCV000057027" DateUpdated="2015-11-20" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Hayette et al. (1995) identified a defect in the EPB42 gene in a 26-year-old Portuguese woman with recessively transmitted hereditary hemolytic anemia (SPH5; 612690). Protein 4.2 was absent from red cell ghosts by Western blotting. Nucleotide sequencing disclosed deletion of a single nucleotide at position 264 (or 265): AAG GTG was changed to AAG TG in codon 88 (or 89) in exon 2. This change, defining allele 4.2 Lisboa, placed in frame the nonsense TGA triplet that normally overlaps codons 136 and 137 (GTG ACC). In effect, codon 89 was changed from GTG (val) to TGA (stop). The mutation was present in homozygous state in the proband and in heterozygous state in the parents and a brother. Apart from anemia, the patient was free of clinical manifestations. Hayette et al. (1995) noted that in this case there were only a few spherocytes and only a limited decrease in the osmotic resistance.</Attribute>
              <Citation>
                <ID Source="PubMed">7803799</ID>
              </Citation>
              <XRef DB="OMIM" ID="612690" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPB42" />
          </GeneList>
          <Name>EPB42, 1-BP DEL, 264G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 264G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="177070.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-LISBOA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="95230" TraitType="Disease" MappingType="Name" MappingValue="SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-LISBOA" MappingRef="Preferred">
        <MedGen CUI="C2675192" Name="Hereditary spherocytosis type 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

